Work

Azithromycin for the Secondary Prevention of Coronary Heart Disease Events: The WIZARD Study: A Randomized Controlled Trial

Year: 2003

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: JAMA

DOI: 10.1001/jama.290.11.1459

Authors: Christopher M. O'Connor, Michael W. Dunne, Marc A. Pfeffer, Joseph B. Muhlestein, Louis Yao, Sandeep Gupta, Rebecca J. Benner, Marian R. Fisher, Thomas D. Cook, for the Investigators in the WIZARD Study

Institutions: Duke University, Pfizer (United States)

Language: English

Topic: Atherosclerosis and Cardiovascular Diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2138998943

FWCI: 11

Cites: 27

Cited by: 327

Related to: 10